Uncategorized

What Impact will the AIM Act have on Ophthalmology?

Posted by

admin

April 1, 2026

On February 10, 2014

Here are some medical technology examples in the field of ophthalmology that can benefit from the AIM Act:

Ophthalmology Presbyopia
Eye implant for presybopia

Ophthalmology Cataract
Flexible IOLs for cataract

Ophthalmology Cataract
Single-piece collagen-copolymer (collamer) based aspheric IOL (Intra Ocular Lens) intended to replace the eye’s natural lens that is removed during the cataract surgery

Ophthalmology Cataract
Lens intended for the treatment of presbyopic and myopic challenges in cataract patients

Ophthalmology Cataract
STAAR Accommodating IOL is an implantable lens intended to treat patients with cataract. Designed to mimic the movement of the natural crystalline lens and eliminates the use of glasses

Ophthalmology Cataract
FluidVision accommodating IOL

Ophthalmology Cataract
Intraocular lens intended for cataract surgery

Ophthalmology Glaucoma
Implant for patients suffering from open-eye glaucoma

Ophthalmology Glaucoma
Wireless measurement of intraocular pressure via RFID-Technology

Ophthalmology Glaucoma
Micro-stent inserted in the eye designed to reduce pressure buildup and prevent glaucoma

Ophthalmology Injured Cornea
Collagen-based contact lens intended for use in ophthalmic procedures designed to restore the vision and to assist in repairing injured cornea

Ophthalmology Presbyopia
Inlay lens made of a proprietary hydrogel material

Ophthalmology Presbyopia
Corneal Inlay to correct presbyopia

Ophthalmology Vision Disorders
Disposable, soft-contact lens intended for the treatment of vision disorders. Made up of PEG material that provides oxygen permeability and water binding properties.

Ophthalmology Visual impairment caused by stroke, brain trauma and glaucoma
Non-invasive brain stimulation device intended for the treatment of visual field defects that result from stroke, brain trauma and glaucoma.

Collection of Information

We collect personally identifiable information like names, postal addresses, email addresses, etc., which are voluntarily submitted by our visitors. MDP is the sole owner of information collected on this site. The information provided is only used to fulfill your specific request, unless you give us permission to use it in another manner, for example to add you to one of our mailing lists for special deals or introduction of new products and services. We do not share any personal information with any third party, period.

Distribution of Information

We reserve the right to disclose your personally identifiable information as required by law and when we believe that disclosure is necessary to protect our rights and/or comply with a judicial proceeding, court order, or legal process served on our web site.

We may share information with governmental agencies or other companies assisting us in fraud prevention or investigation. We may do so when: (1) permitted or required by law or, (2) trying to protect against or prevent actual or potential fraud or unauthorized transactions or, (3) investigating fraud which has already taken place. The information is not provided to these companies for marketing purposes.

We may employ third party companies to perform functions on our behalf. These functions may include order fulfillment, package delivery, marketing assistance, postal and e-mail delivery, customer service, data analysis, and credit processing. The third parties we contract for these purposes have limited access to your personal information and may not use it for other purposes.

Blog

What Impact will the AIM Act have on Ophthalmology?

Leave a Reply Cancel reply

Company

Products

Support

Contact

Collection of Information

Use of IP Addresses

Distribution of Information

Commitment to Data Security

Privacy Contact Information